STELARA
STELARA (ustekinumab) is an immunosuppressant that reduces the effects of a chemical substance in the body that can cause inflammation. Specifically, it is an interleukin-12 and -23 antagonist antibody used to treat psoriasis, Crohn’s disease, and Ulcerative Colitis (UC).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Moderate to severe Plaque Psoriasis,
Active Psoriatic Arthritis alone or
in combination with Methotrexate,
Moderate to severe Crohn's Disease,
Ulcerative Colitis (UC)
Prescribed by
Dermatologists & Gastroenterologists
How it’s administered
Subcutaneous injection or intravenous (IV) infusion, or a combination of both
(depending on the diagnosis)
Frequency
For psoriasis, every 12 weeks (after two starter doses); for UC and Crohn's disease, every 8
weeks (after an IV starter dose)
Length of treatment
10 minutes or less for subcutaneous injection; about an hour for IV infusion